ArticleIndian journal of surgical oncology2025
Synovial Sarcoma of Testis: a Rare Tumour at an Uncommon Site-A Case Report.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neoplasms of testis are relatively rare with an incidence of approximately 1% of cancers in men diagnosed worldwide. Germ cell tumours form around more than 95% of testicular neoplasm. Primary synovial sarcoma of testis is exceedingly rare and soft tissue sarcoma forms around 1% of all adult malignancies. Among sarcomas, synovial sarcoma is about 5 to 10%. It is a mesenchymal tumour which affects children and young adults and mostly involves extremities. This is the second case being reported in the literature. We report the case of a 35-year-old man who presented with a left testicular mass and underwent radical high inguinal orchiectomy. Lost to follow-up, he returned with a recurrent mass in the left inguinoscrotal region. He underwent wide local excision with systemic chemotherapy (a combination of ifosfamide and doxorubicin)and radiotherapy postoperatively. He succumbed to the disease in a year. The prognosis is guarded as the optimal therapy is unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.